News & Updates

Among patients undergoing femoropopliteal artery revascularization, mortality risk was not affected regardless of whether they were treated with drug-coated devices (DCDs) or non–drug-coated devices (NDCDs), according to updated results of the SAFE-PAD* study presented at SCAI 2022.

Patients with relapsed or refractory FLT3-mutated acute myeloid leukaemia (AML) and with prior exposure to tyrosine kinase inhibitors (TKIs) may benefit from gilteritinib treatment, which leads to better remission and survival outcomes than salvage chemotherapy, a recent study has found.

People who love to eat French fries can enjoy this energy-dense food more following a study that says its consumption does not lead to negative health outcomes.

In obese adults, free-living exercise conducted either before or after breakfast leads to notable improvements in body composition and glycaemic control, according to a study presented at the recent 82nd Scientific Sessions by the American Diabetes Association (ADA 2022).

Implantable cardioverter‐defibrillators (ICDs) that are placed subcutaneously is superior to those that are inserted via the axillary–subclavian venous system and placed endocardially, as the former reduces the risk of lead-related complications, according to a meta-analysis. Additionally, subcutaneous ICD appears to be more beneficial in the long term with regard to the risk of device-related complications.